Overview
Status
Suspended
Registry date
2020-06-03
Share capital
500,000.00 PLN
Registered address
Aleja Jana Pawła II 22, 00-133 Warszawa, Poland
Financials
This entity has not filed any financial documents with the Financial Document Repository (RDF).
Industry
Authorized Representatives
Tomasz Marcin Karyś – Management Board Member
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 2,500 | $67,531.06 | 50% | |
Tomasz Marcin Karyśage 43 | 2,500 | $67,531.06 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2020-06-23 to 2024-08-01.
Reason for removal: Art. 96 ust. 9 pkt 4 (taxpayer or their representative fails to appear on summons of tax authorities)
Debt
3 closed proceedings recorded in KRZ history.
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| Oct 29, 2025 | Discontinued enforcement proceedings | Closed | |
| Mar 18, 2025 | Discontinued enforcement proceedings | Closed | |
| Mar 18, 2025 | Discontinued enforcement proceedings | Closed |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| FamicordtxS.A. | $1,365,068.41 | famicordtx.com | ||
| Ecoverseasp. z o.o. | $891,022.45 | coslab.pl | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Explorna Therapeuticssp. z o.o. | $304,662.00 | explorna.com | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| ModicaP.S.A. | $103,400.72 | modica.bio | ||
| AI Corelabsp. z o.o. | $106,857.00 | aicorelab.com | ||
| Orphinic ScientificS.A. | $42,972.42 | orphinic.com | ||
| Bioselsp. z o.o. | $19,100.32 | selol.pl | ||
| Omnisepticasp. z o.o. | $3,475.29 | omniseptica.com |
Change history
| Date | Event | |
|---|---|---|
| 2026-02-16 | Business suspended | |
| 2020-06-03 | Entered in the register |
FAQ
The main business activity of EDI-LAB focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on June 3, 2020.
The headquarters is located at: Aleja Jana Pawła Ii 22, 00-133 Warszawa.
The management board consists of: Tomasz Marcin Karyś (Member of the Management Board).
The share capital of the company is PLN 500,000 (approx. $135,062).
Last updated: 2026-09-16